Of note, CD271 knockdown in 1205Lu melanoma cells that express no detectable level of CD271 do not modify cell viability, whereas CD271 knockdown in SKmel28 and melanoma cells from patient 4 that express a weak but clearly visible expression of CD271 increase the response to vemurafenib. The gene discussed is NGFR; the disease is melanoma.